- £140.54m
- £131.29m
- £32.16m
REG - Diaceutics PLC - Revenue growth of 22% & order book growth of 57%
AnnouncementREG - Diaceutics PLC - Two New Enterprise-Wide Engagements
AnnouncementREG - Diaceutics PLC - Diaceutics - Capital Markets Event
AnnouncementREG - Diaceutics PLC - Notice of Results & Presentations
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/SIP and TVR
AnnouncementREG - Diaceutics PLC - Appointment of Amie Mc Neice as VP of Marketing
AnnouncementREG - Diaceutics PLC - Block Listing Return
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
AnnouncementREG - Diaceutics PLC - Director/PDMR/PCA Shareholding & TR1
AnnouncementRCS - Diaceutics PLC - Significant upgrade to Diaceutics' DXRX platform
AnnouncementRCS - Diaceutics PLC - Diaceutics forms landmark industry Forum
AnnouncementREG - Diaceutics PLC - Director/PDMR Shareholding
AnnouncementREG - Diaceutics PLC - PDMR Shareholding / SIP and TVR
AnnouncementREG - Diaceutics PLC - Expanded lab network and data capabilities
AnnouncementREG - Diaceutics PLC - Diaceutics PLC - Strategic alliance with KPMG
AnnouncementRCS - Diaceutics PLC - Appointment of VP, Scientific & Medical Services
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVR
AnnouncementREG - Diaceutics PLC - Diaceutics PLC – Trading Update
AnnouncementREG - AIM - AIM Notice - 26/01/2024
Announcement